The COVID-19 Pandemic and Indian Pharmaceutical Companies: An Event Study Analysis

C. Behera,B. N. Rath
DOI: https://doi.org/10.21098/BEMP.V24I0.1483
2021-03-08
Buletin Ekonomi Moneter dan Perbankan
Abstract:Although there is a plethora of studies which examine the impact of the COVID-19 pandemic on India’s financial sector, we contribute by investigating the effect of the ongoing COVID-19 pandemic on stock returns of Indian pharmaceutical companies. By employing an event study methodology, our results indicate that the average returns of the pharmaceutical sector are positive during the COVID-19 phase although mixed evidence is found at the firm level. This finding is also robust to alternative model specifications.
Medicine,Business,Economics
What problem does this paper attempt to address?